Overview Financials News + Filings Key Docs Transactions Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Director departure
|
Roivant Sciences Ltd. (ROIV)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/04/2023 |
4
| Venker Eric (COO) has filed a Form 4 on Roivant Sciences Ltd.
Txns:
| Sold 440,752 shares
@ $10.8, valued at
$4.8M
Sold 606,221 shares
@ $10.25, valued at
$6.2M
Sold 153,027 shares
@ $10.11, valued at
$1.5M
Exercised 440,752 options to buy
@ $3.85, valued at
$1.7M
Exercised 606,221 options to buy
@ $3.85, valued at
$2.3M
Exercised 153,027 options to buy
@ $3.85, valued at
$589.2k
|
|
10/04/2023 |
4
| Roivant Sciences Ltd. (10% Owner) has filed a Form 4 on Immunovant, Inc.
Txns:
| Granted 4,473,684 shares
@ $38, valued at
$170M
Bought 1,526,316 shares
@ $38, valued at
$58M
|
|
10/03/2023 |
4
| Pulik Richard (CFO) has filed a Form 4 on Roivant Sciences Ltd.
Txns:
| Disposed of 2,483 shares
@ $11.86, valued at
$29.4k
|
|
10/02/2023 |
4
| MANCHESTER KEITH S (Director) has filed a Form 4 on Roivant Sciences Ltd.
Txns:
| Sold 2,285,783 shares
@ $11.55, valued at
$26.4M
Sold 3,059,368 shares
@ $11.55, valued at
$35.3M
Sold 1,104,599 shares
@ $11.55, valued at
$12.8M
Sold 446,394 shares
@ $11.55, valued at
$5.2M
|
|
10/02/2023 |
4
| SVF Investments (UK) Ltd (10% Owner) has filed a Form 4 on Roivant Sciences Ltd.
Txns:
| Sold 10,000,000 shares
@ $12.6, valued at
$126M
|
|
10/02/2023 |
4
| Gold Daniel Allen (Director) has filed a Form 4 on Roivant Sciences Ltd.
Txns:
| Sold 8,957 shares
@ $11.55, valued at
$103.5k
Sold 2,285,783 shares
@ $11.55, valued at
$26.4M
Sold 3,059,368 shares
@ $11.55, valued at
$35.3M
Sold 3,094,899 shares
@ $11.55, valued at
$35.7M
Sold 1,104,599 shares
@ $11.55, valued at
$12.8M
Sold 446,394 shares
@ $11.55, valued at
$5.2M
|
|
10/02/2023 |
4
| QVT Financial LP (10% Owner) has filed a Form 4 on Roivant Sciences Ltd.
Txns:
| Sold 8,957 shares
@ $11.55, valued at
$103.5k
Sold 2,285,783 shares
@ $11.55, valued at
$26.4M
Sold 3,059,368 shares
@ $11.55, valued at
$35.3M
Sold 3,094,899 shares
@ $11.55, valued at
$35.7M
Sold 1,104,599 shares
@ $11.55, valued at
$12.8M
Sold 446,394 shares
@ $11.55, valued at
$5.2M
|
|
09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/24/2023 |
4
| Kumar Rakhi (Chief Accounting Officer) has filed a Form 4 on Roivant Sciences Ltd.
Txns:
| Disposed of 1,378 shares
@ $10.83, valued at
$14.9k
|
|
08/24/2023 |
4
| Venker Eric (President & COO) has filed a Form 4 on Roivant Sciences Ltd.
Txns:
| Disposed of 16,105 shares
@ $10.83, valued at
$174.4k
|
|
08/24/2023 |
4
| Gline Matthew (CEO) has filed a Form 4 on Roivant Sciences Ltd.
Txns:
| Disposed of 11,015 shares
@ $10.83, valued at
$119.3k
|
|
08/16/2023 |
4
| Venker Eric (COO) has filed a Form 4 on Roivant Sciences Ltd.
Txns:
| Sold 59,811 shares
@ $11.89, valued at
$711.2k
Exercised 59,811 options to buy
@ $3.85, valued at
$230.3k
|
|
08/07/2023 |
4
| Venker Eric (COO) has filed a Form 4 on Roivant Sciences Ltd.
Txns:
| Sold 44,629 shares
@ $11.93, valued at
$532.4k
Exercised 44,629 options to buy
@ $3.85, valued at
$171.8k
|
|
08/03/2023 |
4
| Pulik Richard (CFO) has filed a Form 4 on Roivant Sciences Ltd.
Txns:
| Disposed of 2,306 shares
@ $11.86, valued at
$27.3k
|
|
08/03/2023 |
4
| Gline Matthew (CEO) has filed a Form 4 on Roivant Sciences Ltd.
Txns:
| Disposed of 11,749 shares
@ $11.79, valued at
$138.5k
|
|
08/03/2023 |
4
| Kumar Rakhi (Chief Accounting Officer) has filed a Form 4 on Roivant Sciences Ltd.
Txns:
| Sold 336 shares
@ $12, valued at
$4k
Sold 3,681 shares
@ $12, valued at
$44.2k
Exercised 336 options to buy
@ $6.48, valued at
$2.2k
Exercised 3,681 options to buy
@ $6.48, valued at
$23.9k
|
|
08/02/2023 |
4
| Venker Eric (COO) has filed a Form 4 on Roivant Sciences Ltd.
Txns:
| Sold 117,372 shares
@ $11.91, valued at
$1.4M
Sold 61,397 shares
@ $11.92, valued at
$731.9k
Sold 16,397 shares
@ $11.86, valued at
$194.5k
Exercised 117,372 options to buy
@ $3.85, valued at
$451.9k
Exercised 61,397 options to buy
@ $3.85, valued at
$236.4k
Exercised 16,397 options to buy
@ $3.85, valued at
$63.1k
|
|
08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/27/2023 |
4
| Venker Eric (COO) has filed a Form 4 on Roivant Sciences Ltd.
Txns:
| Sold 28,344 shares
@ $10.86, valued at
$307.8k
Sold 73,568 shares
@ $10.91, valued at
$802.6k
Sold 23,622 shares
@ $10.98, valued at
$259.4k
Exercised 28,344 options to buy
@ $3.85, valued at
$109.1k
Exercised 73,568 options to buy
@ $3.85, valued at
$283.2k
Exercised 23,622 options to buy
@ $3.85, valued at
$90.9k
|
|
07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/06/2023 |
4
| MOMTAZEE JAMES C (Director) has filed a Form 4 on Roivant Sciences Ltd.
Txns:
| Granted 1,664 shares
@ $0 |
|
07/06/2023 |
4
| Epperly Melissa B, (Director) has filed a Form 4 on Roivant Sciences Ltd.
Txns:
| Granted 1,280 shares
@ $0 |
|
|
|
|